Comparable stake leader
Martin Latterich
SEC ownership of Histogen Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001383701.
Disclosed value leader
—
Comparable rows
0/8
Latest evidence
20 Jun 2023
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Martin Latterich
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
20 Jun 2023
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001383701
- Issuer location
- San Diego, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Histogen Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Martin Latterich
Disclosed value leader
—
Comparable rows
0/8
Latest evidence
20 Jun 2023
3/4/5
Some rows are evidence-backed but not safely comparable across classes.
8 rows are not safely comparable across share classes.
Quick read
SEC ownership evidence is available, but the rows are not safely comparable across share classes.
0 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Martin Latterich's linked filing trail.
Detailed SEC evidence table Showing 1-8 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Martin Latterich |
3/4/5
SVP, Technical Operations
|
—
class O/S missing
|
—
134,900 shares
|
— | 17 Feb 2022 |
| Ph.D. Alfred P. Spada |
3/4/5
Executive Vice President and Chief Scientific Officer
|
—
mixed-class rows
|
—
109,007 shares
mixed-class rows
|
— | 23 Feb 2023 |
| Brian Satz |
3/4/5
Director
|
—
class O/S missing
|
—
6,835 shares
|
— | 20 Jun 2023 |
| Daniel L. Kisner |
3/4/5
Director
|
—
class O/S missing
|
—
6,835 shares
|
— | 20 Jun 2023 |
| David H. Crean |
3/4/5
Director
|
—
class O/S missing
|
—
6,835 shares
|
— | 20 Jun 2023 |
| Jonathan Jackson |
3/4/5
Director
|
—
class O/S missing
|
—
6,835 shares
|
— | 20 Jun 2023 |
| Richards Windham Bannister |
3/4/5
Director
|
—
class O/S missing
|
—
6,835 shares
|
— | 20 Jun 2023 |
| Rochelle Fuhrmann |
3/4/5
Director
|
—
class O/S missing
|
—
6,835 shares
|
— | 20 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 01 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-11 of 11 reporting-owner rows connected to Histogen Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
11
Largest Forms 3/4/5 holder
Daniel L. Kisner
Net 12M change
$0
Latest report
20 Jun 2023
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Daniel L. Kisner | Director | Mixed | 20 Jun 2023 | |||
| Brian Satz | Director | Mixed | 20 Jun 2023 | |||
| Jonathan Jackson | Director | Mixed | 20 Jun 2023 | |||
| Susan A. Knudson | COO and CFO | Mixed | 10 Mar 2023 | |||
| Martin Latterich | SVP, Technical Operations | Mixed | 17 Feb 2022 | |||
| Joyce Reyes | Officer | Mixed | 10 Mar 2023 | |||
| Rochelle Fuhrmann | Director | Mixed | 20 Jun 2023 | |||
| Richards Windham Bannister | Director | Mixed | 20 Jun 2023 | |||
| Ph.D. Alfred P. Spada | Executive Vice President and Chief Scientific Officer | Mixed | 23 Feb 2023 | |||
| Steven J. Mento | President and CEO, Director | Mixed | 10 Mar 2023 | |||
| David H. Crean | Director | Mixed | 20 Jun 2023 |
Recent insider transactions for Histogen Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.